Kaplan–Meier estimates indicated a shorter overall survival in patients with ccRCC and low METTL3 protein expression (log‐rank P = .041, see Figure 6), see also detailed information in Supporting Information Table S13. This evidence concerns the gene METTL3 and nonpapillary renal cell carcinoma.